HSBC Holdings’s Tenaya Therapeutics TNYA Stock Holding History

HSBC Holdings’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31,141	Closed	-$45K	–	3265
2024 Q4	$45K	Buy	+31,141	New	+$69.8K	﹤0.01%	3004

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's TNYA Position: Q1 2025 in Review

HSBC Holdings sold out of Tenaya Therapeutics (TNYA) in Q1 2025, closing a stake of 31,141 shares — an estimated $45K sold.

HSBC Holdings first reported a position in TNYA in Q4 2024 and held it in 1 quarter. The position peaked at $45K in Q4 2024. 107 funds tracked by Wall St. Rank hold TNYA as of Q1 2025.

HSBC Holdings reported no remaining Tenaya Therapeutics position as of Q1 2025 after selling out during the quarter.
HSBC Holdings sold 31,141 Tenaya Therapeutics shares in Q1 2025, an estimated $45K.
HSBC Holdings first reported a position in Tenaya Therapeutics in Q4 2024 and held it in 1 quarter.
HSBC Holdings's Tenaya Therapeutics position peaked at $45K in Q4 2024.
107 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2025.

Based on HSBC Holdings's 13F filing for Q1 2025, filed 14 May 2025.